First Horizon Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$57.1K Sell
2,112
-252
-11% -$7.3K ﹤0.01% 931
2025
Q1
$70.1K Sell
2,364
-155
-6% -$5.91K ﹤0.01% 796
2024
Q4
$99.8K Sell
2,519
-77
-3% -$2.92K ﹤0.01% 697
2024
Q3
$88.4K Sell
2,596
-353
-12% -$9.93K ﹤0.01% 767
2024
Q2
$63.9K Sell
2,949
-17
-0.6% -$357 ﹤0.01% 826
2024
Q1
$65.7K Buy
2,966
+37
+1% +$903 ﹤0.01% 838
2023
Q4
$80.6K Sell
2,929
-42
-1% -$1.01K ﹤0.01% 728
2023
Q3
$66.3K Sell
2,971
-819
-22% -$21.1K ﹤0.01% 747
2023
Q2
$96.5K Sell
3,790
-253
-6% -$6.13K ﹤0.01% 659
2023
Q1
$90.2K Sell
4,043
-87
-2% -$2.1K ﹤0.01% 677
2022
Q4
$98K Buy
4,130
+134
+3% +$3.11K ﹤0.01% 615
2022
Q3
$66K Buy
3,996
+275
+7% +$6.19K ﹤0.01% 742
2022
Q2
$73K Buy
3,721
+3,699
+16,814% +$74.7K ﹤0.01% 794
2022
Q1
$1K Sell
22
-1,422
-98% -$40.7K ﹤0.01% 1653
2021
Q4
$59K Buy
1,444
+651
+82% +$28.8K ﹤0.01% 862
2021
Q3
$36K Hold
793
﹤0.01% 1043
2021
Q2
$31K Sell
793
-157
-17% -$6.71K ﹤0.01% 958
2021
Q1
$50K Sell
950
-109
-10% -$6.28K ﹤0.01% 747
2020
Q4
$51K Sell
1,059
-147
-12% -$6.81K ﹤0.01% 597
2020
Q3
$38K Hold
1,206
﹤0.01% 628
2020
Q2
$31K Hold
1,206
﹤0.01% 659
2020
Q1
$28K Buy
1,206
+210
+21% +$5.29K ﹤0.01% 625
2019
Q4
$27K Buy
996
+444
+80% +$11.5K ﹤0.01% 757
2019
Q3
$12K Hold
552
﹤0.01% 1028
2019
Q2
$15K Buy
+552
New +$13.8K ﹤0.01% 961

Other funds holding VCYT

First Horizon Advisors's VCYT Position: Q2 2025 in Review

First Horizon Advisors reduced its Veracyte (VCYT) stake by 11% in Q2 2025, selling an estimated $7.3K and leaving 2,112 shares worth $57.1K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

First Horizon Advisors first reported a position in VCYT in Q2 2019 and has held it in 25 quarters since. The position peaked at $99.8K in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • First Horizon Advisors held 2,112 shares of Veracyte worth $57.1K as of Q2 2025.
  • First Horizon Advisors sold 252 Veracyte shares in Q2 2025, an estimated $7.3K.
  • Veracyte made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #931 holding.
  • First Horizon Advisors first reported a position in Veracyte in Q2 2019 and has held it in 25 quarters since.
  • First Horizon Advisors's Veracyte position peaked at $99.8K in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.